Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
study well documented, meets generally accepted scientific principles, acceptable for assessment

Data source

Reference
Reference Type:
publication
Title:
Unnamed
Year:
1956
Report date:
1956

Materials and methods

Principles of method if other than guideline:
To evaluate the acute toxicity, groups of 5 mice were given graded doses (400, 800, 1600, and 3200 mg/kg bw) of the test substance, followed by a 10 day observation period.
GLP compliance:
no
Test type:
standard acute method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Butyl 2,3-epoxypropyl ether
EC Number:
219-376-4
EC Name:
Butyl 2,3-epoxypropyl ether
Cas Number:
2426-08-6
Molecular formula:
C7H14O2
IUPAC Name:
2-(butoxymethyl)oxirane
Test material form:
liquid
Specific details on test material used for the study:
Name as sited in report: Butyl glycidyl ether (BGE)

Test animals

Species:
mouse
Strain:
other: Princeton
Sex:
male
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Hooper Foundation
- Weight at study initiation: 16-22 gram
- Housing: 5 to a cage
- Diet: Special green powdered diet obtained from the Simonsen Laboratories.

Administration / exposure

Route of administration:
other: intragastrically
Vehicle:
propylene glycol
Details on oral exposure:
Exposure by means of ball-point needle and syringe.

VEHICLE
- Concentration in vehicle: 20%
Doses:
400, 800, 1600, and 3200 mg/kg bw
No. of animals per sex per dose:
5
Control animals:
no
Details on study design:
The animals were held for a 10-day observation period after treatment, during which mortality records were kept and weight changes recorded. Surviving animals were sacrificed for necropsy. Animals were decapitated under light ether anaesthesia. Suitable tissues were taken for histological examination from all moribund animals and animals that died during laboratory hours.

Results and discussion

Effect levels
Key result
Sex:
male
Dose descriptor:
LD50
Effect level:
1 530 mg/kg bw
Based on:
test mat.
95% CL:
>= 1 170 - <= 2 000
Mortality:
At 400 mg/kg bw: No mortality occurred
At 800 mg/kg bw: No mortality occurred.
At 1600 mg/kg bw: 3/5 animals died. Death occurred within 7-15 hours.
At 3200 mg/kg bw: All animals died. Death occurred within 5 minutes.
Gross pathology:
Animals subjected to necropsy showed no gross abnormalities. Histologic examination revealed severe pulmonary congestion in two cases and one case of focal inflammatory cells in the liver.

Applicant's summary and conclusion

Interpretation of results:
Category 4 based on GHS criteria